Donation

The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.

Order Print Edition

 

Full of our informative publications, including our Patient Handbook and selections from the popular Understanding Series, the Info Pack will…

This publication discusses the use of ABECMA® (idecabtagene vicleucel), the first CAR T-cell therapy to be approved by the FDA for patients with…
Blenrep (belantamab mafodotin-blmf) is an antibody-drug conjugate (ADC), the first in a new class of treatments for myeloma. Blenrep is the…

Carvykti™ (ciltacabtagene autoleucel, or “cilta-cel” for short) is a customized immunotherapy approved by the FDA for the treatment of adult…

This publication discusses what myeloma patients should consider if enrolling in a clinical trial.

We Thank Our Sponsors:
BMS, GSK, Janssen, Karyopharm Therapeutics, Legend Biotech, Sanofi, and Takeda Pharmaceuticals U.S.A., Inc.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.